| Detailed information |
|---|
| CancerLivER ID | 2017 |
| Biomarker | CERS4 |
| Biomarker Name/Symbol (given in Publication) | CERS4 |
| Biomolecule | RNAs |
| Subject | Human Cell lines |
| Degree of Validity | Potential marker for liver tumors; but not validated in human subjects |
| Experimental Condition | HCC v/s Normal |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC |
| Level of significance | p < 0.001 |
| Source | Tissue |
| PMID | 28789368 |
| Type of Biomarker | Potential Diagnostic * |
| Pathway | Downregulate NF-κB signaling pathway. |
| Cohort | HepG2 and Huh7 liver cancer cell lines and human 293T cell line |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2017 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |